全文获取类型
收费全文 | 690960篇 |
免费 | 44782篇 |
国内免费 | 1294篇 |
专业分类
耳鼻咽喉 | 9340篇 |
儿科学 | 21668篇 |
妇产科学 | 16963篇 |
基础医学 | 108039篇 |
口腔科学 | 18064篇 |
临床医学 | 61737篇 |
内科学 | 131180篇 |
皮肤病学 | 14803篇 |
神经病学 | 53910篇 |
特种医学 | 24628篇 |
外国民族医学 | 76篇 |
外科学 | 103302篇 |
综合类 | 10812篇 |
现状与发展 | 3篇 |
一般理论 | 348篇 |
预防医学 | 52271篇 |
眼科学 | 16878篇 |
药学 | 52168篇 |
中国医学 | 1212篇 |
肿瘤学 | 39634篇 |
出版年
2021年 | 5888篇 |
2019年 | 6226篇 |
2018年 | 8268篇 |
2017年 | 6044篇 |
2016年 | 6884篇 |
2015年 | 7918篇 |
2014年 | 11062篇 |
2013年 | 17308篇 |
2012年 | 24038篇 |
2011年 | 26315篇 |
2010年 | 15000篇 |
2009年 | 13963篇 |
2008年 | 25016篇 |
2007年 | 26766篇 |
2006年 | 26527篇 |
2005年 | 26302篇 |
2004年 | 25414篇 |
2003年 | 24195篇 |
2002年 | 23710篇 |
2001年 | 25655篇 |
2000年 | 26321篇 |
1999年 | 22225篇 |
1998年 | 7739篇 |
1997年 | 6720篇 |
1996年 | 6737篇 |
1995年 | 6201篇 |
1994年 | 5761篇 |
1992年 | 16834篇 |
1991年 | 17319篇 |
1990年 | 17313篇 |
1989年 | 16654篇 |
1988年 | 15466篇 |
1987年 | 15174篇 |
1986年 | 14467篇 |
1985年 | 13908篇 |
1984年 | 10853篇 |
1983年 | 9433篇 |
1982年 | 6188篇 |
1979年 | 10227篇 |
1978年 | 7771篇 |
1977年 | 6586篇 |
1976年 | 6326篇 |
1975年 | 6973篇 |
1974年 | 8237篇 |
1973年 | 7622篇 |
1972年 | 7348篇 |
1971年 | 6963篇 |
1970年 | 6408篇 |
1969年 | 6106篇 |
1968年 | 5721篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Published data devoted to making and characterization of the properties of polymeric wound dressings with proteolytic action
are reviewed. These data are indicative of individual dependence of the physicochemical properties, activity, and stability
of each particular enzyme on the type of polymer matrix and the method of immobilization. In order to obtain wound dressings,
which are active in physiological medium and retain their activity upon sterilization, it is necessary to optimize the composition
and characteristics of a polymer matrix and the enzyme included into its structure.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 8, pp. 24–28, August, 2006. 相似文献
32.
Lisa A. Lang DDS MS David C. Holmes DDS MS Craig Passon DDS MS Robert M. Trombly DDS JD Jeffrey D. Astroth DDS MSPH Arnold F. Tavel DMD 《Journal of prosthodontics》2003,12(3):206-210
Using complete denture treatment as an introduction to clinical patient care for dental students, the purposes of the Complete Denture Prosthodontics Transition Clinic at the University of Colorado School of Dentistry are to reduce the time lapse between the preclinical complete denture prosthodontics course and the first denture patient experience, and to encourage development of student self-confidence and skills. In the 2002 spring semester, faculty at the University of Colorado School of Dentistry initiated the Complete Denture Prosthodontics Transition Clinic for DS-II (second-year) dental students, as an introduction to clinical patient care. Each patient was assigned to a team of two dental students. Three Division of Prosthodontics faculty members staffed each clinic session, providing a student-to-faculty ratio of approximately 6.6:1 and a patient-to-faculty ratio of approximately 3.3:1. All DS-II students in the Class of 2004 delivered their first complete dentures no later than 8 months (average, 184 days) after the last day of the preclinical complete denture prosthodontics course. The time from the diagnostic appointment through the denture placement appointment averaged 39 days for patients treated in this program, compared with an average of 98 days or more for previous classes. The program was successful in achieving the goal of reducing the time lapse between the preclinical complete denture prosthodontics course and the first denture patient experience. 相似文献
33.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
34.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
35.
36.
37.
38.
Antony E. Shrimpton Robert L. Schelper Reinhold P. Linke John Hardy Richard Crook Dennis W. Dickson Takashi Ishizawa Richard L. Davis 《Neuropathology》2007,27(3):228-232
Over 100 mutations in the presenilin‐1 gene (PSEN1) have been shown to result in familial early onset Alzheimer disease (EOAD), but only a relatively few give rise to plaques with an appearance like cotton wool (CWP) and/or spastic paraparesis (SP). A family with EOAD, seizures and CWP was investigated by neuropathological study and DNA sequencing of the PSEN1 gene. Aβ was identified in leptomeningeal vessels and in cerebral plaques. A single point mutation, p.L420R (g.1508T > G) that gives rise to a missense mutation in the eighth transmembrane (TM8) domain of PS1 was identified in two affected members of the family. p.L420R (g.1508T > G) is the mutation responsible for EOAD, seizures and CWP without SP in this family. 相似文献
39.
40.